36 related articles for article (PubMed ID: 16298653)
1. The effect of sirolimus on prostate-specific antigen (PSA) levels in male renal transplant recipients without prostate cancer.
Chamie K; Ghosh PM; Koppie TM; Romero V; Troppmann C; deVere White RW
Am J Transplant; 2008 Dec; 8(12):2668-73. PubMed ID: 18853950
[TBL] [Abstract][Full Text] [Related]
2. Steroid avoidance or withdrawal for pancreas and pancreas with kidney transplant recipients.
Montero N; Webster AC; Royuela A; Zamora J; Crespo Barrio M; Pascual J
Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD007669. PubMed ID: 25220222
[TBL] [Abstract][Full Text] [Related]
3. Selective corticosteroid and calcineurin-inhibitor withdrawal after pancreas-kidney transplantation utilizing thymoglobulin induction and sirolimus maintenance therapy.
Knight RJ; Kerman RH; McKissick E; Lawless A; Podder H; Katz S; Van Buren CT; Kahan BD
Clin Transplant; 2008; 22(5):645-50. PubMed ID: 18657156
[TBL] [Abstract][Full Text] [Related]
4. Graft survival and immune regulation of pancreas allograft recipients induced with thymoglobulin, sirolimus, and cyclosporine.
Knight RJ; Kerman RH; Podder H; Katz SM; Van Buren CT; Kahan BD
Transplant Proc; 2005 Mar; 37(2):1280-2. PubMed ID: 15848695
[TBL] [Abstract][Full Text] [Related]
5. Pancreas transplantation utilizing thymoglobulin, sirolimus, and cyclosporine.
Knight RJ; Kerman RH; Zela S; Podbielski J; Podder H; Van Buren CT; Katz S; Kahan BD
Transplantation; 2006 Apr; 81(8):1101-5. PubMed ID: 16641593
[TBL] [Abstract][Full Text] [Related]
6. Thymoglobulin, sirolimus, and reduced-dose cyclosporine provides excellent rejection prophylaxis for pancreas transplantation.
Knight RJ; Kerman RH; Zela S; Podder H; Van Buren CT; Katz S; Kahan BD
Transplantation; 2003 Apr; 75(8):1301-6. PubMed ID: 12717220
[TBL] [Abstract][Full Text] [Related]
7. Comparing an early corticosteroid/late calcineurin-free immunosuppression protocol to a sirolimus-, cyclosporine A-, and prednisone-based regimen for pancreas-kidney transplantation.
Knight RJ; Podder H; Kerman RH; Lawless A; Katz SM; Van Buren CT; Gaber AO; Kahan BD
Transplantation; 2010 Mar; 89(6):727-32. PubMed ID: 20195219
[TBL] [Abstract][Full Text] [Related]
8. A pilot study of immunosuppression minimization after pancreas-kidney transplantation utilizing thymoglobulin induction and sirolimus maintenance therapy.
Knight RJ; Kerman RH; McKissick E; Lawless A; Podder H; Katz S; Van Buren CT; Kahan BD
Transplant Proc; 2005 Oct; 37(8):3538-41. PubMed ID: 16298653
[TBL] [Abstract][Full Text] [Related]
9. Sirolimus: a ten-year perspective.
Kahan BD
Transplant Proc; 2004; 36(1):71-5. PubMed ID: 15013304
[TBL] [Abstract][Full Text] [Related]
10. Sirolimus: a current perspective.
Yakupoglu YK; Kahan BD
Exp Clin Transplant; 2003 Jun; 1(1):8-18. PubMed ID: 15859902
[TBL] [Abstract][Full Text] [Related]
11. Steroid elimination-who, when, how?
Matas AJ
Transplant Proc; 2008 Dec; 40(10 Suppl):S52-6. PubMed ID: 19100910
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]